DBTX Annual EBITDA
-$62.49 M
-$13.68 M-28.02%
31 December 2022
Summary:
As of February 5, 2025, DBTX annual earnings before interest, taxes, depreciation & amortization is -$62.49 million, with the most recent change of -$13.68 million (-28.02%) on December 31, 2022. During the last 3 years, it has fallen by -$20.18 million (-47.69%).DBTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Quarterly EBITDA
-$18.72 M
-$4.94 M-35.82%
30 June 2023
Summary:
As of February 5, 2025, DBTX quarterly earnings before interest, taxes, depreciation & amortization is -$18.72 million, with the most recent change of -$4.94 million (-35.82%) on June 30, 2023. Over the past year, it has dropped by -$1.98 million (-11.81%).DBTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX TTM EBITDA
-$64.60 M
-$1.98 M-3.16%
30 June 2023
Summary:
As of February 5, 2025, DBTX TTM earnings before interest, taxes, depreciation & amortization is -$64.60 million, with the most recent change of -$1.98 million (-3.16%) on June 30, 2023. Over the past year, it has dropped by -$7.25 million (-12.65%).DBTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | -11.8% | -12.7% |
| 3 y3 years | -47.7% | -151.7% | -164.3% |
| 5 y5 years | -71.8% | - | -998.3% |
DBTX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +71.8% | +218.2% | +998.3% |
Decibel Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$18.72 M(+35.8%) | -$64.60 M(+3.2%) |
| Mar 2023 | - | -$13.78 M(-14.5%) | -$62.62 M(+0.2%) |
| Dec 2022 | -$62.49 M(+28.0%) | -$16.11 M(+0.8%) | -$62.49 M(+6.0%) |
| Sept 2022 | - | -$15.99 M(-4.5%) | -$58.98 M(+2.8%) |
| June 2022 | - | -$16.74 M(+22.6%) | -$57.35 M(+10.3%) |
| Mar 2022 | - | -$13.65 M(+8.4%) | -$51.99 M(+6.5%) |
| Dec 2021 | -$48.82 M | -$12.59 M(-12.3%) | -$48.82 M(-0.1%) |
| Sept 2021 | - | -$14.36 M(+26.1%) | -$48.89 M(+18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$11.39 M(+8.7%) | -$41.22 M(+10.6%) |
| Mar 2021 | - | -$10.48 M(-17.3%) | -$37.27 M(-1.7%) |
| Dec 2020 | -$37.92 M(-10.4%) | -$12.66 M(+89.2%) | -$37.92 M(+21.8%) |
| Sept 2020 | - | -$6.69 M(-10.0%) | -$31.14 M(+27.4%) |
| June 2020 | - | -$7.44 M(-33.2%) | -$24.45 M(+43.7%) |
| Mar 2020 | - | -$11.13 M(+89.2%) | -$17.01 M(+189.2%) |
| Dec 2019 | -$42.31 M(+16.3%) | -$5.88 M | -$5.88 M |
| Dec 2018 | -$36.38 M | - | - |
FAQ
- What is Decibel Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Decibel Therapeutics?
- What is Decibel Therapeutics annual EBITDA year-on-year change?
- What is Decibel Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly EBITDA year-on-year change?
- What is Decibel Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Decibel Therapeutics?
- What is Decibel Therapeutics TTM EBITDA year-on-year change?
What is Decibel Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DBTX is -$62.49 M
What is the all time high annual EBITDA for Decibel Therapeutics?
Decibel Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$36.38 M
What is Decibel Therapeutics annual EBITDA year-on-year change?
Over the past year, DBTX annual earnings before interest, taxes, depreciation & amortization has changed by -$13.68 M (-28.02%)
What is Decibel Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DBTX is -$18.72 M
What is the all time high quarterly EBITDA for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.88 M
What is Decibel Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DBTX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.98 M (-11.81%)
What is Decibel Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DBTX is -$64.60 M
What is the all time high TTM EBITDA for Decibel Therapeutics?
Decibel Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.88 M
What is Decibel Therapeutics TTM EBITDA year-on-year change?
Over the past year, DBTX TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.25 M (-12.65%)